HU-345
 | |
| Identifiers | |
|---|---|
| |
| PubChem (CID) | 11198119 |
| ChemSpider |
9373188  |
| ChEMBL |
CHEMBL127671 |
| Chemical and physical data | |
| Formula | C21H24O3 |
| Molar mass | 324.414 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
HU-345 (cannabinol quinone) is a drug that is able to inhibit aortic ring angiogenesis more potently than its parent compound cannabinol.[1][2]
See also
References
- ↑ Natalya M. Kogan; et al. (2006). "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells". Molecular Pharmacology. 70 (1): 51–59. doi:10.1124/mol.105.021089. PMID 16571653.
- ↑ US patent 0092584, Mechoulam R, Kogan NM, Rabinowitz R, Schlesinger M, "Therapeutic Use of Quinonoid Derivatives of Cannabinoids", granted 2011-04-21
This article is issued from Wikipedia - version of the 8/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.